EWA
RYTM icon

EverSource Wealth Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

EverSource Wealth Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.77K Sell
70
-479
-87% -$43.3K ﹤0.01% 3057
2026
Q1 		$47.7K Buy
549
+283
+106% +$27.5K ﹤0.01% 1922
2025
Q4 		$28.5K Buy
266
+200
+303% +$21.2K ﹤0.01% 2147
2025
Q3 		$6.67K Buy
66
+1
+2% +$93 ﹤0.01% 3021
2025
Q2 		$4.11K Buy
65
+46
+242% +$2.82K ﹤0.01% 3243
2025
Q1 		$1.01K Buy
19
+7
+58% +$388 ﹤0.01% 3228
2024
Q4 		$672 Buy
+12
New +$663 ﹤0.01% 3095

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EverSource Wealth Advisors's RYTM Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Rhythm Pharmaceuticals (RYTM) stake by 87% in Q2 2026, selling an estimated $43.3K and leaving 70 shares worth $7.77K. The position accounts for ﹤0.01% of the portfolio, ranked #3057.

EverSource Wealth Advisors first reported a position in RYTM in Q4 2024 and has held it in 7 quarters since. The position peaked at $47.7K in Q1 2026. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • EverSource Wealth Advisors held 70 shares of Rhythm Pharmaceuticals worth $7.77K as of Q2 2026.
  • EverSource Wealth Advisors sold 479 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $43.3K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3057 holding.
  • EverSource Wealth Advisors first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • EverSource Wealth Advisors's Rhythm Pharmaceuticals position peaked at $47.7K in Q1 2026.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.